NEWS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of LV305 Immuno-Oncology Agent View HTML
Toggle Summary Immune Design's GLAAS Discovery Platform Used in MEDI7510 Phase 1 Trial for Respiratory Syncytial Virus View HTML
Toggle Summary Immune Design Appoints Franklin M. Berger to Board of Directors View HTML
Toggle Summary Immune Design Appoints William Ringo to Board of Directors View HTML
Toggle Summary Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G305 Cancer Immunotherapy Agent View HTML
Toggle Summary Immune Design to Present at Upcoming Investor Conferences in February View HTML
Toggle Summary Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G100, an Investigational Immuno-Oncology Agent View HTML
Toggle Summary Immune Design Raises Up to $49 Million Series C Financing
Immune Design Raises Up to $49 Million Series C Financing SEATTLE and SAN FRANCISCO , Oct. 30, 2013 /PRNewswire/ -- Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced it has closed a Series C
View HTML
Toggle Summary Immune Design Appoints Frank J. Hsu, M.D., Vice President, Head of Oncology
Immune Design Appoints Frank J. Hsu, M.D., Vice President, Head of Oncology SAN FRANCISCO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotech company focused on the development of novel immune-based therapies for cancer and other human diseases, today announced the appointment of Frank J.
View HTML
Toggle Summary Immune Design Appoints Jan Henrik ter Meulen, M.D., Chief Scientific Officer
Immune Design Appoints Jan Henrik ter Meulen, M.D., Chief Scientific Officer SEATTLE and SAN FRANCISCO, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the
View HTML